首页> 美国卫生研究院文献>ACS Chemical Neuroscience >Identification of Specific Ligand–ReceptorInteractions That Govern Binding and Cooperativity of Diverse Modulatorsto a Common Metabotropic Glutamate Receptor 5 Allosteric Site
【2h】

Identification of Specific Ligand–ReceptorInteractions That Govern Binding and Cooperativity of Diverse Modulatorsto a Common Metabotropic Glutamate Receptor 5 Allosteric Site

机译:特定配体受体的鉴定控制各种调制器的绑定和协作性的交互常见的代谢型谷氨酸受体5变构位点

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A common metabotropic glutamate receptor 5 (mGlu5) allosteric site is known to accommodate diverse chemotypes. However, the structural relationship between compounds from different scaffolds and mGlu5 is not well understood. In an effort to better understand the molecular determinants that govern allosteric modulator interactions with mGlu5, we employed a combination of site-directed mutagenesis and computational modeling. With few exceptions, six residues (P654, Y658, T780, W784, S808, and A809) were identified as key affinity determinants across all seven allosteric modulator scaffolds. To improve our interpretation of how diverse allosteric modulators occupy the common allosteric site, we sampled the wealth of mGlu5 structure–activity relationship (SAR) data available by docking 60 ligands (actives and inactives) representing seven chemical scaffolds into our mGlu5 comparative model. To spatially and chemically compare binding modes of ligands from diverse scaffolds, the ChargeRMSD measure was developed. We found a common binding mode for the modulators that placed the long axes of the ligands parallel to the transmembrane helices 3 and 7. W784 in TM6 not only was identified as a key NAMcooperativity determinant across multiple scaffolds, but also causeda NAM to PAM switch for two different scaffolds. Moreover, a singlepoint mutation in TM5, G747V, altered the architecture of the commonallosteric site such that 4-nitro-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide (VU29) was noncompetitive withthe common allosteric site. Our findings highlight the subtletiesof allosteric modulator binding to mGlu5 and demonstratethe utility in incorporating SAR information to strengthen the interpretationand analyses of docking and mutational data.
机译:常见的代谢型谷氨酸受体5(mGlu5)变构位点可适应多种化学型。但是,来自不同支架的化合物与mGlu5之间的结构关系尚不十分清楚。为了更好地理解与mGlu5调控变构调节剂相互作用的分子决定簇,我们采用了定点诱变和计算模型的组合。除少数例外,在所有七个变构调节剂支架中,六个残基(P654,Y658,T780,W784,S808和A809)被确定为关键亲和力决定因素。为了改善我们对各种变构调节剂如何占据共同变构位点的解释,我们通过将代表七个化学支架的60个配体(活性和非活性)对接到我们的mGlu5比较模型中,对大量的mGlu5结构-活性关系(SAR)数据进行了采样。为了在空间和化学上比较来自不同支架的配体的结合模式,开发了ChargeRMSD测量。我们发现,将配体的长轴与跨膜螺旋3和7平行放置的调节剂的常见结合模式。TM6中的W784不仅被确定为关键NAM跨多个支架的决定因素,但也导致NAM到PAM开关,用于两个不同的支架。而且,一个TM5中的点突变G747V改变了通用的架构等位基因位点,使得4-硝基-N-(1,3-二苯基-1H-吡唑-5-基)苯甲酰胺(VU29)与常见的变构位点。我们的发现突出了微妙之处变构调节剂与mGlu5结合并证明整合SAR信息以加强解释的实用程序以及对接和突变数据的分析。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号